Agree will be interesting Tez.
Its the first time we may get revenue guidance.
As stated in the Quarterly, Allume have given
Anteotech forecast of expected increasing volumes of Anteobind required for 2020-2021. Not sure it will be enough to be Cash flow neutral. But if the Allume agreement has the ability to propel Anteotech into a cash flow neutral /profit position in 2021 or 2022 Tax year then ADO should shout it from the roof.
The ADO snowball is starting to roll!
GLTA
Annual Report, page-2
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $57.91M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.3¢ | $14.64K | 628.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 2785605 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 1158542 | 8 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.4¢ |
Change
0.000 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 2.3¢ | 2.4¢ | 2.3¢ | 1060873 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| ADO (ASX) Chart |